Clinical Trial Update: A Long Term Safety Extension Study (CHS-0214-05) [Phase 3]

View source ↗

Summary

Phase 3 long-term safety extension study for a therapy in rheumatoid arthritis and plaque psoriasis has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis
• Rheumatoid Arthritis

Snippet

Sponsor: Coherus Oncology, Inc. | Conditions: Rheumatoid Arthritis, Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2018-12-27